SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Andrew A. Nierenberg, MD

Speaker Affiliation
Andrew A. Nierenberg, MD
Thomas P. Hackett Endowed Chair in Psychiatry at MGH
Bipolar Clinic and Research Program
Massachusetts General Hospital
Harvard Medical School
Boston, MA

email: info@adhdinadults.com
Title
: Comorbid and Reverse Comorbid Bipolar Disorder and ADHD
Activity/Course #:
: NCMEDP135
Cost:
: Free
Release/Start Date:
: Dec 11 2018
Expiration Date:
: Dec 10 2019
Topics:
: Psychiatry
Target Audience:
: Primary Care Providers
Format:
: ADHD Dissemination Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
Hardware/Software Requirements:
In this webcast, Dr. Nierenberg describes different major networks in the brain and their function; discusses diagnosis of dysregulations in ADHD and bipolar patients; identifies appropriate medications for ADHD and Bipolar Disorder; and explains the switching problems that patients may have among brain modes.

This webcast was recorded live and is being used with the permission of the presenter.

Learning Objectives

At the conclusion of this activity, the learner will be able to:

       1. Describe different major networks in the brain and their function
       2. Recognize and diagnose dysregulations in ADHD and bipolar patients
       3. Prescribe appropriate medications for ADHD and Bipolar Disorder
       4. Explain to patients the switching problems they have among brain modes

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Creditô. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure is provided below.

Dr. Nierenberg has served as a consultant for Alfasigma, Alkermes, NeuroRx Pharma, Sunovion, Naurex, Hoffman LaRoche/Genentech, Eli Lilly and Company, Pfizer, Shire, Teva, and Jazz Pharmaceuticals. Dr. Nierenberg serves on the advisory board for SLACK Inc. Dr. Nierenberg conducts research for NeuroRx Pharma, Marriott Foundation, NIH, Brain and Behavior Research Foundation, Janssen, and PCORI.

In the past year, Dr. Faraone received income, potential income, travel expenses continuing education support and/or research support from Lundbeck, Rhodes, Arbor, KenPharm, Ironshore, Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA, Sunovion, Genomind and Neurolifesciences. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In previous years, he received support from: Shire, Neurovance, Alcobra, Otsuka, McNeil, Janssen, Novartis, Pfizer and Eli Lilly. Dr. Faraone receives royalties from books published by Guilford Press: Straight Talk about Your Childís Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is principal investigator of www.adhdinadults.com. Dr. Faraone is supported by the K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway, the European Unionís Seventh Framework Programme for research; technological development and demonstration under grant agreement no 602805, the European Unionís Horizon 2020 research and innovation programme under grant agreement No 667302 and NIMH grants 5R01MH101519 and U01 MH109536-01.

Jonathan Marx, Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, CHCP, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an independent medial educational grant from Shire.